J&J | JNJ - Net Income

Stock Price
227.79
Daily Change
2.45 1.09%
Monthly
-6.06%
Yearly
46.10%
Q2 Forecast
222.63

J&J reported $5.24B in Net Income for its fiscal quarter ending in March of 2026.





Net Income Change Date
AbbVie USD 1.82B 1.63B Dec/2025
Abbott USD 1.08B 699M Mar/2026
Amgen USD 1.33B 1.88B Dec/2025
AstraZeneca USD 2.33B 207M Dec/2025
Baxter International USD -1.13B 1.08B Dec/2025
Bayer EUR -3.76B 2.79B Dec/2025
Becton, Dickinson and Co. USD 382M 111M Dec/2025
Biogen USD 466.5M 168.3M Sep/2025
Boston Scientific USD 1.34B 669M Mar/2026
Bristol-Myers Squibb USD 1.09B 1.11B Dec/2025
CONMED USD 16.74M 13.88M Dec/2025
Cooper Companies USD 130.8M 46.2M Dec/2025
Dexcom USD 267.3M 16.5M Dec/2025
Edwards Lifesciences USD 380.7M 289.5M Mar/2026
Eli Lilly USD 6.64B 1.05B Dec/2025
Gilead Sciences USD 2.18B 869M Dec/2025
GlaxoSmithKline GBP 636M 1.38B Dec/2025
Globus Medical USD 140.59M 21.63M Dec/2025
Insulet USD 101.6M 14M Dec/2025
Integra LifeSciences USD -1.7M 3.7M Dec/2025
Intuitive Surgical USD 821.5M 26.7M Mar/2026
J&J USD 5.24B 119M Mar/2026
Medtronic USD 1.14B 231M Dec/2025
Merck USD 2.96B 2.82B Dec/2025
Merit Medical Systems USD 27.76M 4.83M Sep/2025
Novartis USD 2.41B 1.52B Dec/2025
Pfizer USD -1.65B 5.19B Dec/2025
Regeneron Pharmaceuticals USD 844.6M 615.4M Dec/2025
Roche Holding CHF 5.47B 1.76B Dec/2025
Sanofi EUR 1.61B 2.42B Mar/2026
Stryker USD 849M 10M Dec/2025
Tandem Diabetes Care USD -589K 20.58M Dec/2025
Teva Pharmaceutical Industries USD 480M 47M Dec/2025
Vertex Pharmaceuticals USD 1.19B 108.2M Dec/2025
Zimmer Biomet Holdings USD 139.3M 91.6M Dec/2025
Zoetis USD 603M 118M Dec/2025